This activity is provided by Physicians’ Education Resource®, LLC.
Hidradenitis suppurativa (HS) is a chronic, immune-mediated, inflammatory skin disease associated with significant morbidity due to recurrence of disease flares, pain, malodorous drainage of abscesses, and comorbidities. Early intervention is important, but there is evidence indicating that diagnosis can be delayed for many years, during which time the majority of patients report multiple physician consultations before receiving an accurate diagnosis. This delayed or missed diagnosis often results in fragmented care and inappropriate treatments, which contribute to disease progression and morbidity. Treatment options for HS encompass both pharmacologic and nonpharmacologic interventions, but the limited availability of evidence supporting the use of available treatments has made it difficult to recommend a single treatment strategy. Furthermore, HS has proven to be a challenging condition that requires a comprehensive, multidisciplinary, individualized management approach. These educational resources contribute to the optimization of HS management by presenting the latest research, exploring the role of investigational agents for the treatment of HS, and discussing care strategies that enhance the patient experience and improve outcomes.
Outline psychosocial issues faced by patients with HS in special populations that impact quality of life
Develop multidisciplinary care plans for patients with HS based on shared goals of therapy
This activity is designed to provide an expert disease overview of hidradenitis suppurativa (HS) and interpretation of new and emerging options for diagnosis and treatment, with a forward-looking perspective on how new staging guidelines and novel therapeutic agents might impact clinical practice
Est. Activity Time: 210 minutes total for all 4 activities
Additional resources >> HERE